Dimple Rahul Desai, PA-C

Dimple Desai practices at Florida Medical Clinic Orlando Health Urgent Care in Zephyrhills, Florida.

Dimple Desai's NPI, 1497085930, was assigned on January 6, 2010. Dimple Desai holds Florida license PA9105309.

Dimple Desai's primary practice is Florida Medical Clinic Orlando Health Urgent Care, at 38021 Market Square Dr, Zephyrhills, FL 33542. The practice phone is (813) 715-0374.

Dimple Desai's primary practice is Florida Medical Clinic Orlando Health Urgent Care in Zephyrhills, Florida. Dimple Desai is also affiliated with Orlando Health Bayfront Hospital. The medical group on file is Florida Medical Clinic Orlando Health. Dmand AI also links Dimple Desai to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dimple Desai practices, 4 sites in all. Vendor and product names are available with a free account.

Medical is Dimple Desai's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Dimple Desai is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dimple Desai is licensed in Florida.

Dmand AI lists gout, joint or bone infection, lower back pain, osteoporosis, psoriasis, rash and rheumatoid arthritis among the conditions Dimple Desai treats.

CMS data shows 1,047 Medicare services from Dimple Desai across 5 procedure codes in 2024, for 505 Medicare patients. Medicare paid $54,746 for them. Every service was in an office.

CMS counts 505 Medicare patients who saw Dimple Desai in 2024. The largest group is 65 to 74, with 229 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dimple Desai's median patient age at 73, with 88% women.

In 2024, Dimple Desai wrote 1,531 Medicare Part D claims for 321 patients. 70% of them were for generic drugs. CMS names the drug for 1,358 of them, across 29 drugs with 11 or more claims each, at $2,061,925 in total drug cost.

Dimple Desai accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dimple Desai as offering telehealth.

CMS Open Payments shows 255 general payments to Dimple Desai from 20 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,512. It also lists 1 research payment totaling $1,721 in 2024, naming 1 clinical trial.